Drozd Robert, Rychlik Michal, Fijalkowska Agata, Rygula Rafal
Affective Cognitive Neuroscience Laboratory, Department of Pharmacology, Institute of Pharmacology Polish Academy of Sciences, 12 Smetna Street, 31-343, Krakow, Poland.
Affective Cognitive Neuroscience Laboratory, Department of Pharmacology, Institute of Pharmacology Polish Academy of Sciences, 12 Smetna Street, 31-343, Krakow, Poland.
Behav Brain Res. 2019 Feb 1;359:619-629. doi: 10.1016/j.bbr.2018.10.003. Epub 2018 Oct 4.
Depressive disorders are often associated with cognitive biases. In this study, we investigated, in an animal model, whether cognitive judgement bias, measured as a stable and enduring behavioural trait, could modulate the effects of antidepressant drugs on other cognitive processes associated with depression. For this purpose, we identified rats displaying 'pessimistic' and 'optimistic' traits in a series of ambiguous-cue interpretation (ACI) tests. Subsequently, in the preclinical version of the probabilistic reversal-learning (PRL) test, allowing multiple reversals within a test session, we compared the effects of acute administration of 5 different antidepressant (AD) drugs (agomelatine, escitalopram, clomipramine, mirtazapine and venlafaxine) on cognitive flexibility and sensitivity to positive/negative feedback in optimistic and pessimistic animals. We report that, following acute treatment with agomelatine, the proportion of lose-shift behaviours in the PRL test was significantly reduced in pessimistic animals compared to optimists. We also demonstrate that acute treatment with another antidepressant drug, mirtazapine, significantly increased the sensitivity of rats to positive feedback, as indexed by the increased proportion of win-stay behaviour following probabilistic reward. This effect was independent of cognitive bias and was associated with a reduced number of reversals made by the animals. Three other tested drugs had no significant effects on behavioural measures assessed in our study.
抑郁症常常与认知偏差相关。在本研究中,我们在动物模型中探究了作为一种稳定且持久行为特征来衡量的认知判断偏差是否能够调节抗抑郁药物对与抑郁症相关的其他认知过程的影响。为此,我们在一系列模糊线索解释(ACI)测试中识别出表现出“悲观”和“乐观”特征的大鼠。随后,在概率反转学习(PRL)测试的临床前版本中,该测试允许在一个测试环节内进行多次反转,我们比较了5种不同抗抑郁(AD)药物(阿戈美拉汀、艾司西酞普兰、氯米帕明、米氮平和文拉法辛)急性给药对乐观和悲观动物认知灵活性以及对正/负反馈敏感性的影响。我们报告称,与乐观动物相比,阿戈美拉汀急性治疗后,悲观动物在PRL测试中输-转换行为的比例显著降低。我们还证明,另一种抗抑郁药物米氮平急性治疗显著提高了大鼠对正反馈的敏感性,这以概率奖励后赢-保持行为比例增加为指标。这种效应与认知偏差无关,并且与动物做出的反转次数减少有关。其他三种受试药物对我们研究中评估的行为指标没有显著影响。